BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 18025068)

  • 1. Pancreatic cancer regression by intratumoural injection of live Streptococcus pyogenes in a syngeneic mouse model.
    Maletzki C; Linnebacher M; Kreikemeyer B; Emmrich J
    Gut; 2008 Apr; 57(4):483-91. PubMed ID: 18025068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lysates of S. pyogenes serotype M49 induce pancreatic tumor growth delay by specific and unspecific antitumor immune responses.
    Linnebacher M; Maletzki C; Emmrich J; Kreikemeyer B
    J Immunother; 2008 Oct; 31(8):704-13. PubMed ID: 18779749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transfection with CD40L induces tumour suppression by dendritic cell activation in an orthotopic mouse model of pancreatic adenocarcinoma.
    Serba S; Schmidt J; Wentzensen N; Ryschich E; Märten A
    Gut; 2008 Mar; 57(3):344-51. PubMed ID: 17675324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of an antitumoral immune response by wild-type adeno-associated virus type 2 in an in vivo model of pancreatic carcinoma.
    Eisold S; Schmidt J; Ryschich E; Gock M; Klar E; von Knebel Doeberitz M; Linnebacher M
    Pancreas; 2007 Jul; 35(1):63-72. PubMed ID: 17575547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The early interferon response of nasal-associated lymphoid tissue to Streptococcus pyogenes infection.
    Hyland KA; Brennan R; Olmsted SB; Rojas E; Murphy E; Wang B; Cleary PP
    FEMS Immunol Med Microbiol; 2009 Apr; 55(3):422-31. PubMed ID: 19243434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetically induced pancreatic adenocarcinoma is highly immunogenic and causes spontaneous tumor-specific immune responses.
    Garbe AI; Vermeer B; Gamrekelashvili J; von Wasielewski R; Greten FR; Westendorf AM; Buer J; Schmid RM; Manns MP; Korangy F; Greten TF
    Cancer Res; 2006 Jan; 66(1):508-16. PubMed ID: 16397267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of anti-tumor immunity by high levels of Th1 and Th17 with a combination of dendritic cell fusion hybrids and regulatory T cell depletion in pancreatic cancer.
    Yamamoto M; Kamigaki T; Yamashita K; Hori Y; Hasegawa H; Kuroda D; Moriyama H; Nagata M; Ku Y; Kuroda Y
    Oncol Rep; 2009 Aug; 22(2):337-43. PubMed ID: 19578774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Individual mouse analysis of the cellular immune response to tumor antigens in peripheral blood by intracellular staining for cytokines.
    Giannetti P; Facciabene A; La Monica N; Aurisicchio L
    J Immunol Methods; 2006 Oct; 316(1-2):84-96. PubMed ID: 17010367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The contribution of dendritic cells to host defenses against Streptococcus pyogenes.
    Loof TG; Rohde M; Chhatwal GS; Jung S; Medina E
    J Infect Dis; 2007 Dec; 196(12):1794-803. PubMed ID: 18190260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon-alpha enhances antitumor effect of chemotherapy in an orthotopic mouse model for pancreatic adenocarcinoma.
    Zhu Y; Tibensky I; Schmidt J; Ryschich E; Märten A
    J Immunother; 2008 Sep; 31(7):599-606. PubMed ID: 18600184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of natural killer cells to the pathogenesis of septic shock induced by Streptococcus pyogenes in mice.
    Goldmann O; Chhatwal GS; Medina E
    J Infect Dis; 2005 Apr; 191(8):1280-6. PubMed ID: 15776374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Allogeneic dendritic cell vaccine pulsed with heat shocked tumor cell lysate can enhance antitumor immunity].
    You J; Wang CL; Hao XS
    Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(39):2785-90. PubMed ID: 18167273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo vaccination with tumor cell lysate plus CpG oligodeoxynucleotides eradicates murine glioblastoma.
    Wu A; Oh S; Gharagozlou S; Vedi RN; Ericson K; Low WC; Chen W; Ohlfest JR
    J Immunother; 2007; 30(8):789-97. PubMed ID: 18049330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amniotic membrane transplantation induces apoptosis in T lymphocytes in murine corneas with experimental herpetic stromal keratitis.
    Bauer D; Wasmuth S; Hennig M; Baehler H; Steuhl KP; Heiligenhaus A
    Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3188-98. PubMed ID: 19255156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Active-specific immunotherapy of pancreatic carcinoma: usefulness of human pancreatic carcinomas in preparing autologous tumor vaccines.
    Grossmann A; Rameken M; Klapdor R
    Anticancer Res; 1997; 17(4B):3117-9. PubMed ID: 9329615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In situ vaccination against a non-immunogenic tumour using intratumoural injections of liposomal interleukin 2.
    Neville ME; Robb RJ; Popescu MC
    Cytokine; 2001 Dec; 16(6):239-50. PubMed ID: 11884028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenovirus-mediated interferon alpha gene transfer induces regional direct cytotoxicity and possible systemic immunity against pancreatic cancer.
    Ohashi M; Yoshida K; Kushida M; Miura Y; Ohnami S; Ikarashi Y; Kitade Y; Yoshida T; Aoki K
    Br J Cancer; 2005 Aug; 93(4):441-9. PubMed ID: 16106250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole cell ELISA for measuring anti-tumour effects of immunotherapies in a mouse tumour model of ALCL.
    Carstens M; Bittner C; Krokowski M; Hadlak M; Feller AC; Merz H
    In Vivo; 2003; 17(4):359-63. PubMed ID: 12929591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cell dependence of chronic destructive murine arthritis induced by repeated local activation of Toll-like receptor-driven pathways: crucial role of both interleukin-1beta and interleukin-17.
    Joosten LA; Abdollahi-Roodsaz S; Heuvelmans-Jacobs M; Helsen MM; van den Bersselaar LA; Oppers-Walgreen B; Koenders MI; van den Berg WB
    Arthritis Rheum; 2008 Jan; 58(1):98-108. PubMed ID: 18163514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CCL21 induces extensive intratumoral immune cell infiltration and specific anti-tumor cellular immunity.
    Turnquist HR; Lin X; Ashour AE; Hollingsworth MA; Singh RK; Talmadge JE; Solheim JC
    Int J Oncol; 2007 Mar; 30(3):631-9. PubMed ID: 17273764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.